SCHEMBL29840567

SCHEMBL29840567

COCCCOc1cc(CC(=O)C(C)(C)C)ccc1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 2/20 0.40
▸ CA2 P00918 1/20 0.40
▸ PPARD Q03181 1/20 0.40
▸ PPARA Q07869 1/20 0.40
▸ KDM4E B2RXH2 6/20 0.39
▸ MAPK1 P28482 3/20 0.38
▸ MAPT P10636 3/20 0.38
▸ ATM Q13315 1/20 0.38
▸ LMNA P02545 2/20 0.38
▸ HDAC8 Q9BY41 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ ALDH1A1 P00352 4/20 0.38
▸ CYP2C19 P33261 2/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ USP2 O75604 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ ALOX12 P18054 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16929982 1.00 PPARG (0.40) PPARGCA2PPARDPPARAKDM4E
SCHEMBL17721710 0.88 PPARA (0.38) PPARGCA2PPARDPPARAKDM4E
SCHEMBL19087207 0.88 PPARA (0.38) PPARGCA2PPARDPPARAKDM4E
SCHEMBL16930243 0.85 REN (0.48) PPARAMAPTLMNAHTTMEN1
SCHEMBL16930147 0.83 KDM4E (0.41) CA2PPARDPPARAKDM4EMAPK1
SCHEMBL29840555 0.83 KDM4E (0.41) CA2PPARDPPARAKDM4EMAPK1
SCHEMBL19815542 0.82 PPARA (0.41) PPARGPPARDPPARAKDM4EMAPK1
SCHEMBL21175742 0.82 CA2 (0.39) CA2KDM4EALDH1A1HPGD
SCHEMBL8285816 0.80 ALDH1A1 (0.43) KDM4EMAPK1MAPTATMLMNA
SCHEMBL16929923 0.80 CA2 (0.38) PPARGCA2PPARDPPARAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109715624-B Novel therapeutic agents for the treatment of HBV infection 广州麓鹏制药有限公司 2022-08-16 — — CN disclosed
Send feedback